Edwards Lifesciences Net Worth

Edwards Lifesciences Net Worth Analysis

Edwards Lifesciences Target Price Consensus

Edwards Lifesciences Target Price Projection

Edwards Lifesciences' current and average target prices are 71.51 and 79.57, respectively. The current price of Edwards Lifesciences is the price at which Edwards Lifesciences Corp is currently trading. On the other hand, Edwards Lifesciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Edwards Lifesciences Corp and the information provided on this page.

Know Edwards Lifesciences' Top Institutional Investors

Note, although Edwards Lifesciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Edwards Lifesciences' market capitalization trends

The company currently falls under 'Large-Cap' category with a market capitalization of 41.42 B.

Project Edwards Lifesciences' profitablity

The company has Net Profit Margin (PM) of 0.77 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.26 %, which signifies that for every $100 of sales, it has a net operating income of $0.26.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Edwards Lifesciences' management efficiency

Edwards Lifesciences Corp has Return on Asset (ROA) of 0.0826 % which means that for every $100 of assets, it generated a profit of $0.0826. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1664 %, which means that it produced $0.1664 on every 100 dollars invested by current stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.43 in 2025. Return On Capital Employed is likely to climb to 0.14 in 2025. At this time, Edwards Lifesciences' Return On Tangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.31 in 2025, whereas Debt To Assets are likely to drop 0.05 in 2025.

Edwards Lifesciences Corporate Filings

Edwards Lifesciences time-series forecasting models is one of many Edwards Lifesciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Edwards Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Edwards Lifesciences Earnings Estimation Breakdown

The calculation of Edwards Lifesciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Edwards Lifesciences is estimated to be 0.5959 with the future projection ranging from a low of 0.58 to a high of 0.64. Please be aware that this consensus of annual earnings estimates for Edwards Lifesciences Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.

Edwards Lifesciences Earnings Projection Consensus

Edwards Lifesciences Earnings History

Earnings estimate consensus by Edwards Lifesciences Corp analysts from Wall Street is used by the market to judge Edwards Lifesciences' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Edwards Lifesciences' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At this time, Edwards Lifesciences' Retained Earnings are fairly stable compared to the past year. Retained Earnings Total Equity is likely to climb to about 9.2 B in 2025, whereas Price Earnings Ratio is likely to drop 10.07 in 2025. Net Income Applicable To Common Shares is likely to climb to about 1.8 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 548 M in 2025.

Hype Prediction Low Estimated High 69.81 71.43 73.05 Details

Intrinsic Valuation Low Real High 64.36 75.67 77.29 Details

Naive Forecast Low Next High 73.40 75.02 76.64 Details

33 Analysts Consensus Low Target High 72.41 79.57 88.33 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Edwards assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Edwards Lifesciences. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Edwards Lifesciences' stock price in the short term.

Edwards Lifesciences Earnings per Share Projection vs Actual

Actual Earning per Share of Edwards Lifesciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Edwards Lifesciences Corp predict the company's earnings will be in the future. The higher the earnings per share of Edwards Lifesciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Edwards Lifesciences Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Edwards Lifesciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Edwards Lifesciences should always be considered in relation to other companies to make a more educated investment decision.

Edwards Quarterly Analyst Estimates and Surprise Metrics

Edwards Lifesciences Corporate Directors

Additional Tools for Edwards Stock Analysis